Docking study and free energy simulation of the complex between p53 DNA-binding domain and azurin

Journal of Molecular Recognition

Volumn 20, Issue 4, 2007, Pages 215-226

  De Grandis, Valentina ^a   Bizzarri, Anna Rita ^a   Cannistraro, Salvatore ^a  

^a UNIVERSITY OF TUSCIA   (Italy)

Author keywords

Azurin; Docking; Free energy; Molecular dynamics simulation; p53

Indexed keywords

AZURIN; PROTEIN P53;

ARTICLE; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER SIMULATION; ENERGY METABOLISM; HUMAN; METABOLISM; METHODOLOGY; PHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; PSEUDOMONAS AERUGINOSA; SITE DIRECTED MUTAGENESIS; VALIDATION STUDY;

AZURIN; BINDING SITES; COMPUTER SIMULATION; ENERGY METABOLISM; HUMANS; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEIN STRUCTURE, TERTIARY; PSEUDOMONAS AERUGINOSA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34948865835     PISSN: 09523499     EISSN: 10991352     Source Type: Journal    
DOI: 10.1002/jmr.840     Document Type: Article

References (56)

1. Apiyo D, Wittung-Stafshede P. 2005. Unique complex between bacterial azurin and tumor-suppressor protein p53. Biochem. Biophys. Res. Commun. 332: 965-968.
2. Arcangeli C, Bizzarri AR, Cannistraro S. 1999. Long-term molecular dynamics simulation of copper azurin: structure, dynamics and functionality. Biophys. Chem. 78: 247-257.
3. Baker NA, Sept D, Joseph S, Holst MJ, McCammon JA. 2001. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc. Natl. Acad. Sci. USA 98: 10037-10041.
4. Bell S, Hansen S, Buchner J. 2002. Refolding e structural characterization of the human p53 tumor suppressor protein. Biophys. Chem. 96: 243-257.
5. Berendsen HJC, Postma JPM, van Gunsteren WF, Hermans J. 1969. Interaction models for water in relation to protein hydration. Nature 224: 175-177.
6. Bizzarri AR. 2006. Topological and dynamical properties of Azurin anchored to a gold substrate as investigated by molecular dynamics simulation. Biophys. Chem. 122: 206-214.
7. Bizzarri AR, Brunori E, Bonanni B, Cannistraro S. 2007. Docking and molecular dynamics simulation of the azurin-cytochrome c551 electron transfer complex. J. Mol. Recogn. 20: 122-131.
8. Bonander N, Leckner J, Guo H, Karlsson BG, Sjölin L. 2000. Crystal structure of the disulfide bond-deficient azurin mutant C3A/C26A. How important is the S-S bond for folding and stability? Eur. J. Biochem. 267: 4511-4519.
9. Bonanni B, Kamruzzahan ASM, Bizzarri AR, Rankl C, Gruber HJ, Hinterdorfer P, Cannistraro S. 2005. Single molecule recognition between cytochrome C 551 and gold-immobilized azurin by force spectroscopy. Biophys. J. 89: 2783-2791.
10. 2+ interactions: possibilities and limitations of a simple pairwise force field. J. Mol. Graph. Model. 24: 404-411.
11. Cascella M, Magistrato A, Tavernelli I, Carloni P, Rothlisberger U. 2006. Role of protein frame and solvent for the redox properties of azurin from Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 103: 19641-19646.
12. Chen R, Weng Z. 2002. Docking unbound proteins using shape complementarity, desolvation, and electrostatics. Proteins: Struct. Funct. Genet. 47: 281-294.
13. Chen R, Weng Z. 2003. A novel shape complementarity scoring function for protein-protein docking. Proteins: Struct. Funct. Genet. 51: 397-408.
14. Cho Y, Gorina S, Jeffrey PD, Pavletich NP. 1994. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265: 346-355.
15. Chong LT, Duan Y, Wang L, Massova I, Kollman PA. 1999. Molecular dynamics and free-energy calculations applied to affinity maturation in antibody 48G7. Proc. Natl. Acad. Sci. USA 96: 14330-14335.
16. Clore GM, Omichinski JG, Sakaguchi K, Zambrano N, Sakamoto H, Appella E, Gronenborn AM. 1994. High-resolution structure of the oligomerization domain of p53 by multidimensional NMR. Science 265: 386-391.
17. Comeau SR, Gatchell DW, Vajda S, Camacho CJ. 2004. ClusPro: a fully automated algorithm for protein- protein docking. Nucleic Acids Res. 32: 96-99.
18. Dawson R, Muller L, Dehner A, Klein C, Kessler H, Buchner J. 2003. The N-terminal domain of p53 is natively unfolded. J. Mol. Biol. 332: 1131-1141.
19. De Rienzo F, Gabdoulline RR, Menziani MC, Wade RC. 2000. Blue copper proteins: a comparative analysis of their molecular interaction properties. Protein Sci. 9: 1439-1454.
20. 2+ on DNA recognition and stability of the p53 DNA-binding domain. Biochemistry 45: 7483-7492.
21. Ganoth A, Friedman R, Nachliel E, Gutman M. 2006. A molecular dynamics study and free energy analysis of complexes between the MIc1p protein and two IQ motif peptides. Biophys. J. 91: 2436-2450.
22. Guex N, Peitsch MC. 1997. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18: 2714-2723.
23. Halperin I, Ma B, Wolfson H, Nussinov R. 2002. Principles of docking: an overview of search algorithms and a guide to scoring functions. Proteins: Struct. Funct. Genet. 47: 409-443.
24. Hess B, Bekker H, Berendsen HJC, Fraaije JGEM. 1997. LINCS: a linear constraint solver for molecular simulations. J. Comp. Chem. 18: 1463-1472.
25. Ho WC, Luo C, Zhao K, Chai X, Fitzgerald MX, Marmorstein R. 2006. High-resolution structure of the p53 core domain: implications for binding small-molecule stabilizing compounds. Acta Cryst. D62: 1484-1493.
26. Humphrey WF, Dalke A, Schulten K. 1996. VMD - visual molecular dynamics. J. Mol. Graph. 14: 33-38.
27. Jeffrey PD, Gorina S, Pavletich NP. 1995. Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms. Science 267: 1498-1502.
28. Joerger AC, Ang HC, Fersht AR. 2006. Structural basis for understanding oncogenic p53 mutations and designing rescue drugs. Proc. Natl. Acad. Sci. USA 103: 15056-15061.
29. Jones S, Thornton JM. 1996. Principles of protein-protein interactions derived from structural studies. Proc. Natl. Acad. Sci. USA 93: 13-20.
30. Klein C, Planker E, Diercks T, Kessler H, Künkele KP, Lang K, Hansen S, Schwaiger M. 2001. NMR spectroscopy reveals the solution dimerization interface of p53 core domains bound to their consensus DNA. J. Biol. Chem. 276: 49020-49027.
31. Liu J, Pan Y, Ma B, Nussinov R. 2006. 'Similarity trap' in protein-protein interactions could be carcinogenic: simulations of p53 core domain complexed with 53BP1 and BRCA1 BRCT domains. Structures 14: 1811-1821.
32. Lu Q, Lu HP, Wang J. 2007. Exploring the mechanism of flexible biomolecular recognition with single molecule dynamics. Phys. Rev. Lett. 98: 128105-1-128105-4.
33. Masatoshi G, Yamada T, Kimbara K, Horner J, Newcomb M, Das Gupta TK, Chakrabarty AM. 2003. Induction of apoptosis in macrophages by Pseudomonas aeruginosa azurin: tumor-suppressor protein p53 and reactive oxygen species, but not redox activity, as critical elements in cytotoxicity. Mol. Microbiol. 47: 549-559.
34. Massova I, Kollman PA. 1999. Computational alanine scanning to probe protein-protein interactions: a novel approach to evaluate binding free energies. J. Am. Chem. Soc. 121: 8133-8143.
35. Maynard AT, Covell DG. 2001. Reactivity of zinc finger cores: analysis of protein packing and electrostatic screening. J. Am. Chem. Soc. 123: 1047-1058.
36. McDonald IK, Thornton JM. 1994. Satisfying hydrogen-bonding potential in proteins. J. Mol. Biol. 238: 777-793.
37. Nar H, Messerschmidt A, Huber R, van de Kamp M, Canters GW. 1991. Crystal structure analysis of oxidized Pseudomonas aeruginosa azurin at pH 5.5 and pH 9.0. A pH-induced conformational transition involves a peptide bond flip. J. Mol. Biol. 221: 765-772.
38. Nooren IMA, Thornton JM. 2003. Structural characterization and functional significance of transient protein-protein interactions. J. Mol. Biol. 325: 991-1018.
39. Pan Y, Ma B, Venkataraghavan RB, Levine AJC, Nussinov R. 2005. In the quest for stable rescuing mutants of p53: computational mutagenesis of flexible loop L1. Biochemistry 44: 1423-1432.
40. Pan Y, Ma B, Levine AJ, Nussinov R. 2006. Comparison of the human and worm p53 structures suggests a way for enhancing stability. Biochemistry 45: 3925-3933.
41. Pérez Cañadillas JM, Tidow H, Freund SMV, Rutherford TJ, Ang HC, Fersht AR. 2006. Solution structure of p53 core domain: structural basis for its instability. Proc. Natl. Acad. Sci. USA 103: 2109-2114.
42. Punji V, Das Gupta TK, Chakrabarty AM. 2003. Bacterial cupredoxin azurin and its interactions with the tumor suppressor protein p53. Biochem. Biophys. Res. Commun. 312: 109-114.
43. Punj V, Bhattacharyya S, Saint-Die D, Vasu C, Cunningham EA, Graves J, Yamada T, Constantinou Al, Christov K, White B, Li G, Majumdar D, Chakrabarty AM, Das Gupta TK. 2004. Bacterial cupredoxin azurin as an inducer of apoptosis and regression in human breast cancer. Oncogene 23: 2367-2378.
44. Sheinerman FB, Norel R, Honig B. 2000. Electrostatic aspects of protein-protein interactions. Curr. Opin. Struct. Biol. 10: 153-159.
45. Srinivasan J, Cheatham TE, Cieplak P, Kollman PA, Case DA. 1998. Continuum solvent studies of the stability of DNA, RNA, and phosphoramidate - DNA helices. J. Am. Chem. Soc. 120: 9401-9409.
46. Swart M. 2002. Density functional theory applied to copper proteins. PhD Thesis; Groningen, Rijksuniversiteit Groningen.
47. Vajda S, Camacho CJ. 2004. Protein-protein docking: is the glass half-full or half-empty? Trends Biotechnol. 22: 110-116.
48. van der Spoel D, van Buuren AR, Apol E, Meulenhoff PJ, Tieleman DP, Sijbers ALTM, Hess B, Feenstra KA, Lindahl E, van Drunen R, Berendsen HJC. 2001. GROMACS User Manual. University of Groningen, Groningen: The Netherlands; Version 3.2.
49. Veprintsev DB, Freund SMV, Andreeva A, Rutledge SE, Tidow H, Pérez Cañadillas JM, Blair CM, Fersht AR. 2006. Core domain interactions in full-length p53 in solution. Proc. Natl. Acad. Sci. USA 103: 2115-2119.
50. Vogelstein B, Lane DP, Levine AJ. 2000. Surfing the p53 network. Nature 408: 307-310.
51. Webb MA, Loppnow GR. 1999. A structural basis for long-range coupling in azurins from resonance Raman spectroscopy. J. Phys. Chem. A 103: 6283-6287.
52. Weinberg RL, Freund SMV, Veprintsev DB, Bycroft M, Fersht AR. 2004. Regulation of DNA binding of p53 by its C-terminal domain. J. Mol. Biol. 342: 801-811.
53. Wong KB, DeDecker BS, Freund SMV, Proctor MR, Bycroft M, Fersht AR. 1999. Hot-spot mutants of p53 core domain evince characteristic local structural changes. Proc. Natl. Acad. Sci. USA 96: 8438-8442.
54. Wu Y, Cao Z, Yi H, Jiang D, Mao X, Liu H, Li W. 2004. Simulation of the interaction between ScyTx and small conductance calcium-activated potassium channel by docking and MM-PBSA. Biophys. J. 87: 105-112.
55. Yamada T, Goto M, Punj V, Zaborina O, Chen ML, Kimbara K, Majumdar D, Cunningham E, Das Gupta TK, Chakrabarty AM. 2002. Bacterial redox protein azurin, tumor suppressor protein p53, and regression of cancer. Proc. Natl. Acad. Sci. USA 99: 14098-14103.
56. Yamada T, Hiraoka Y, Ikehata M, Kimbara K, Avner BS, Das Gupta TK, Chakrabarty AM. 2004. Apoptosis or growth arrest: modulation of tumor suppressor p53's specificity by bacterial redox protein azurin. Proc. Natl. Acad. Sci. USA 101: 4770-4775.